Toremifene
98%
- Product Code: 102985
CAS:
89778-26-7
| Molecular Weight: | 405.96 g./mol | Molecular Formula: | C₂₆H₂₈ClNO |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Toremifene is primarily used in the treatment of breast cancer, particularly in postmenopausal women with estrogen receptor-positive or unknown metastatic breast cancer. It functions as a selective estrogen receptor modulator (SERM), binding to estrogen receptors and blocking the effects of estrogen on breast tissue, which helps to inhibit the growth of cancer cells.
In clinical practice, Toremifene is often prescribed as an alternative to tamoxifen, especially for patients who may not tolerate tamoxifen well. It is administered orally and is generally well-tolerated, with side effects being manageable in most cases.
Beyond its primary use in breast cancer, Toremifene has also been explored for its potential in treating other estrogen-dependent conditions, although its application in these areas is less established. Ongoing research continues to investigate its efficacy and safety in broader therapeutic contexts.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White Solid |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿10,260.00 |
+
-
|
| 0.500 | 10-20 days | ฿29,800.00 |
+
-
|
Toremifene
Toremifene is primarily used in the treatment of breast cancer, particularly in postmenopausal women with estrogen receptor-positive or unknown metastatic breast cancer. It functions as a selective estrogen receptor modulator (SERM), binding to estrogen receptors and blocking the effects of estrogen on breast tissue, which helps to inhibit the growth of cancer cells.
In clinical practice, Toremifene is often prescribed as an alternative to tamoxifen, especially for patients who may not tolerate tamoxifen well. It is administered orally and is generally well-tolerated, with side effects being manageable in most cases.
Beyond its primary use in breast cancer, Toremifene has also been explored for its potential in treating other estrogen-dependent conditions, although its application in these areas is less established. Ongoing research continues to investigate its efficacy and safety in broader therapeutic contexts.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :